ArticleDiagnostics (Basel, Switzerland)2022
A Proposed Framework for Early Prediction of Schistosomiasis.
Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 26 citations in OpenAlex.
- Review
- Enhancing patient rehabilitation outcomes: artificial intelligence-driven predictive modeling for home discharge in neurological and orthopedic conditions.Journal of neuroengineering and rehabilitation · 2025Article
- Stacking model framework reveals clinical biochemical data and dietary behavior features associated with type 2 diabetes: A retrospective cohort study.APL bioengineering · 2024Article
- Therapeutic Potential of Natural Products in the Treatment ofMolecules (Basel, Switzerland) · 2023Review
- Article
- Robots for Elderly Care: Review, Multi-Criteria Optimization Model and Qualitative Case Study.Healthcare (Basel, Switzerland) · 2023Article
- Human-Computer Interaction with a Real-Time Speech Emotion Recognition with Ensembling Techniques 1D Convolution Neural Network and Attention.Sensors (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 6 institutions in 4 countries.
Funding
Abstract
Schistosomiasis is a neglected tropical disease that continues to be a leading cause of illness and mortality around the globe. The causing parasites are affixed to the skin through defiled water and enter the human body. Failure to diagnose Schistosomiasis can result in various medical complications, such as ascites, portal hypertension, esophageal varices, splenomegaly, and growth retardation. Early prediction and identification of risk factors may aid in treating disease before it becomes incurable. We aimed to create a framework by incorporating the most significant features to predict Schistosomiasis using machine learning techniques. A dataset of advanced Schistosomiasis has been employed containing recovery and death cases. A total data of 4316 individuals containing recovery and death cases were included in this research. The dataset contains demographics, socioeconomic, and clinical factors with lab reports. Data preprocessing techniques (missing values imputation, outlier removal, data normalisation, and data transformation) have also been employed for better results. Feature selection techniques, including correlation-based feature selection, Information gain, gain ratio, ReliefF, and OneR, have been utilised to minimise a large number of features. Data resampling algorithms, including Random undersampling, Random oversampling, Cluster Centroid, Near miss, and SMOTE, are applied to address the data imbalance problem. We applied four machine learning algorithms to construct the model: Gradient Boosting, Light Gradient Boosting, Extreme Gradient Boosting and CatBoost. The performance of the proposed framework has been evaluated based on Accuracy, Precision, Recall and F1-Score. The results of our proposed framework stated that the CatBoost model showed the best performance with the highest accuracy of (87.1%) compared with Gradient Boosting (86%), Light Gradient Boosting (86.7%) and Extreme Gradient Boosting (86.9%). Our proposed framework will assist doctors and healthcare professionals in the early diagnosis of Schistosomiasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.